Patent · US Active

Anti-OX40 antibodies and uses thereof

US11999790B2 · kind B2 · utility

0Cited by
7References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 5, 2021
Grant dateJun 4, 2024
Priority date—
Expiry dateMay 5, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure relates to anti-human OX40 (TNF Receptor Superfamily Member 4, or TNFRSF4) antibodies, antigen-binding fragments, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.